Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
OSE Immunotherapeutics' Global License to Develop a Novel Monoclonal Antibody…
OSE Immunotherapeutics' Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes EffectiveNANTES, France, April 16, 2024 – OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnemo: OSE), a clinical-stage immunotherapy company, today announced that the Hart-Scott-Rodino waiting period has expired with respect to its global license with AbbVie to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently...
Nasdaq GlobeNewswire
16/04/2024
VIRBAC: Building on the momentum of the second half of 2023, strong…
KEY FIGURES Revenue1 stquarter 2024 € 345.7MGrowth at constant exchange rates and scope 1 +9.7%of whichcompanion animals +16.2% farm animals +1.2%Growth at constant exchange rates +10.8% Overall change +9.8% 1 growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the...
Nasdaq GlobeNewswire
16/04/2024
Human Identification Market Worth $1.3 billion | MarketsandMarkets™
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100607777 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100607777 Browse in-depth TOC on "Human Identification Market" 262 - Tables 42 - Figures 242 - Pages Human Identification Market Scope: In 2023, the consumables segment held the largest share of the human identification market by product segment. Based on product, the...
PR Newswire
16/04/2024
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3%…
Prime Determinants of Growth Prime Determinants of Growth The emphysema treatment market has experienced significant growth owing to rise in prevalence of emphysema cases globally. Furthermore, rise in number of smokers has contributed in the increasing prevalence of emphysema. In addition,Asia-Pacificis expected to present significant opportunities for growth owing to rise in awareness programs for emphysema, increasing diagnosis and increase in investments for well-developed...
PR Newswire
16/04/2024
Asthma - Market Outlook, Epidemiology, Competitive Landscape, and Market…
Asthma is a chronic inflammatory respiratory disease, which affects adults as well as pediatrics. In the United States, it affects approximately 25 million people, including 5 million children/adolescents. About 1 million asthmatic people in the United States get hospitalized each year. Globally, asthma impacts more than 250 million people, reflecting high disease burden. In addition to the age-group, asthma patients can be categorized into mild, moderate or severe patients, based on the disease…
PR Newswire
16/04/2024
The Nomination Committee's proposal for the election of Board members and…
The Nomination Committee proposes that Eugen Steiner, Cecilia Edström, Pär Gellerfors, Lars Lannfelt, Lotta Ljungqvist and Mikael Smedeby be re-elected as board members and that Anna-Lena Engwall be elected as new board member, each for a term of office until the end of the next annual general meeting. Furthermore, the Nomination Committee proposes that Eugen Steiner be re-elected as chairperson. The Nomination Committee proposes thatEugen Steiner, Cecilia Edström, Pär Gellerfors, Lars...
PR Newswire
16/04/2024
TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR
The demand for these services is driven by the over 2500 cell and gene therapies being developed in the United States and Europe and the progress of technologies involving CRISPR, AAV vectors, and mRNA therapeutics. These innovations require rigorous molecular analyses and adherence to regulated guidelines for bioanalysis and safety testing, including biodistribution, pharmacokinetics, transgene expression, and shedding throughout the developmental stages of therapies. The demand for these...
PR Newswire
16/04/2024
CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution
"The cell and gene therapy industry needs more solutions that integrate data with products, alongside a global network with advanced capabilities and service infrastructure," said Patrick Schafer, CSafe CEO. "Our team has worked tirelessly to develop these new solutions to ensure the integrity of our customers' valuable cargo, and ultimately provide peace of mind." "The cell and gene therapy industry needs more solutions that integrate data with products, alongside a…
PR Newswire
16/04/2024
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for…
SOLANA BEACH, Calif., April 16, 2024 /PRNewswire/ -- Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), today announced The Medicines and Healthcare products Regulatory Agency (MHRA) authorization of NULIBRY® (fosdenopterin) for Injection as the first therapy for the treatment of patients in Great Britain (GB) with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that…
PR Newswire
16/04/2024
INSIGHTEC ANNOUNCES EXABLATE PRIME AVAILABILITY IN EUROPE -THE NEXT GENERATION…
Like its predecessor, Exablate Prime enables incisionless neurosurgery as an outpatient procedure to provide relief to people living with movement disorders, such as essential tremor and Parkinson's disease. New improvements include an enriched user interface and enhancements to optimize productivity. Specific improvements include: Like its predecessor, Exablate Prime enables incisionless neurosurgery as an outpatient procedure to provide relief to people living with movement disorders, such…
PR Newswire
16/04/2024
IMC to transfer its Oranim Pharmacy shares back to the seller
About IM Cannabis Corp. About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients inIsraelandGermany, two of the largest medical cannabis markets. The Company has recently exited operations inCanadato pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets,IsraelandGermany. The Company leverages a transnational ecosystem powered by...
PR Newswire
16/04/2024
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial…
Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion's Board of Directors “Najat brings a unique blend of leadership in biological, chemical, and medical sciences, data science, and business,” said Chris Gibson, Co-Founder and CEO of Recursion. “More importantly, she has a vision and passion for transforming drug discovery and development that complements ours and...
Nasdaq GlobeNewswire
16/04/2024
Vistin Pharma ASA: Invitation to Q1 2024 conference call
Vistin Pharma ASA will release its first quarter results on Wednesday 24 thof April 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Wednesday 24 thof April at 08:30 CET. There will be a Q&A session following the management discussion.The conference call will be held in English.The first quarter conference call will be available via web and audio through the following access points: Webcast: https://edge...
Nasdaq GlobeNewswire
16/04/2024
Anti-Aging Supplements to Hit US$ 2,161 Million by 2034 Fueled by Aging…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19469 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19469 Several factors are anticipated to boost growth of the healthy aging supplement industry during the next ten years. These include increasing consumer awareness about health and well-being, growing senior citizen...
PR Newswire
16/04/2024
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Company Announcement Net sales of DARZALEX ®in the first quarter of 2024 totaled USD 2,692 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; April 16, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ®(daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEXFASPRO®in the U.S...
Nasdaq GlobeNewswire
16/04/2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage…
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV® Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as planned. Research & Development (R&D) investments increased by 14.2% to EUR 5.8 billion. R&D investments were substantial, at 22...
Nasdaq GlobeNewswire
16/04/2024
Renowned British Plastic Surgeon Mr. Norman Waterhouse Joining Bizrahmed, Dubai
Mr. Waterhouse comes to Bizrahmed with over 30 years of work experience in plastic surgery, specialising in areas such as facelift, neck lift, body lift, liposuction and other body aesthetic surgeries. He has a special technique learnt in Brazil, which is the net suturing that eliminates the need to wear post-operative garments during day time and quickens recovery. Mr. Waterhouse comes to Bizrahmed with over 30 years of work experience in plastic surgery, specialising in areas such as...
PR Newswire
16/04/2024
ELFBAR zeros in on vape recyclability in continuous dedication
ELFBAR Corrugated Paper Vape ELFBAR Corrugated Paper Vape In another latest example of bringing innovation by doubling down on developing recycling technologies, the brand showcases R3, a single-use vape prototype users can detach the battery on their own for more hassle-free recycling. Minimalist concept boosted by corrugated paper The award-winning single-use vape applies degradable corrugated paper to its entire shell, an inspiration that originates from cardboard furniture and...
PR Newswire
16/04/2024
Renowned Industry Expert Peter Kyobe Waiswa Joins XRP Healthcare to transform…
Peter Kyobe Waiswa brings an illustrious background as a Ugandan researcher, medical doctor, and academic administrator. As an associate professor of Health Policy, Planning, and Management at Makerere University, he has demonstrated expertise in health policy and health systems, particularly in maternal, newborn, and child health in low and middle-income countries. Peter Kyobe Waiswa brings an illustrious background as a Ugandan researcher, medical doctor, and academic administrator...
PR Newswire
16/04/2024
Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and…
Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024Halle (Saale) / Munich, Germany, April 16, 2024- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will publish its financial results for the full year...
Nasdaq GlobeNewswire
16/04/2024
Active Nutraceuticals Ingredients Market Projected to Reach $392.58 billion by…
The landscape of the nutraceutical industry is experiencing a transformative shift, attributed to an escalating global consciousness towards health and wellness, alongside the evolution of cutting-edge extraction and processing methodologies. This shift enables the seamless integration of active nutraceutical ingredients into a wealth of products to bolster health, ward off chronic diseases, and extend lifespan. The movement is further supported by governmental endorsements worldwide, ensuring…
PR Newswire
16/04/2024
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 -…
Using revolutionary advances in liquid biopsies, genetic testing, and artificial intelligence (AI), multi-cancer screening emerges as a pivotal breakthrough in oncology research, offering an exceptional ability to identify various cancers, such as lung, breast, colorectal, and prostate. This innovative approach significantly improves patient outcomes by facilitating timely and more effective treatment paths. Fuelled by a surge in global cancer rates and increased awareness of the benefits of…
PR Newswire
16/04/2024
Nebulizer Market Projected to Reach $3.97 billion by 2030 - Exclusive Report by…
Nebulizers play a crucial role by converting liquid medications into fine mists and facilitating direct inhalation into the lungs, as this is a vital instrument in managing respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other lung conditions. This medication delivery method ensures efficient absorption and aids in rapid symptom relief for individuals requiring pulmonary treatment. The prevalence of respiratory disorders, attributed to…
PR Newswire
16/04/2024
LG OFFERS EXTRAORDINARY LIFESTYLE EXPERIENCE IN COLLABORATION WITH MOOOI AT…
A Must-see Exhibition: Innovative in Home Appliances as Objet d'Art A Must-see Exhibition: Innovative in Home Appliances as Objet d'Art Moooi's "creative luxury" is immediately apparent in each engaging and elegant display that makes up the memorable exhibit. The Dutch company's curated furniture pieces, lightings, patterns and interior accessories are perfectly paired with a wide range of stylish, premium LG appliances. Among these are the PuriCare™️ AeroFurniture, InstaView™...
PR Newswire
16/04/2024
Altri Comunicati